Table 3.
List of organic compounds detected by GC–MS after derivatization of the ethyl acetate extract derived from rhizospheric distillery sludge and their impact in environment
| S. no. | Compounds | RT | Environmental impact | References |
|---|---|---|---|---|
| 1. | Benzene, 1-ethyl-3,5-disopropyl | 8.19 | – | – |
| 2. | Butanedioic acid, bis(TMS)ester | 9.01 | – | – |
| 3. | Propanoic acid, 3-[(TMS)oxy], TMS ester | 9.08 | – | – |
| 4. | Heptacosane | 10.25 | – | – |
| 5. | 17-Pentatriacontene | 10.88 | – | – |
| 6. | Ethyl-TMS dipropylmalonate | 11.17 | – | – |
| 7. | Tert-Hexadecanethiol | 12.85 | – | – |
| 8. | 1-Hexadecanol, 2 methyl | 13.72 | – | – |
| 9. | Tricarballylic Acid TMS | 14.65 | Inhibit citric acid cycle in mammals | Russell and Forsberg (1986) |
| 10. | Ethanedioic acid, bis(TMS)ester; | 15.45 | – | – |
| 11. | 2-Monostearin TMS ether | 16.55 | – | – |
| 12. | Octadecanoic acid, 2,3-bis[(TMS)oxy]propyl ester | 17.50 | – | – |
| 13. | Butanedioic acid, bis(TMS) ester | 17.65 | – | – |
| 14. | 2-Monostearin TMS ether | 20.01 | – | – |
| 15. | 2-Methyl-1,3-Propanediol 2TMS | 21.23 | – | – |
| 16. | Pyrrolozine1-one,7-propyl | 21.88 | – | – |
| 17. | Dotriacontane | 22.98 | – | – |
| 18. | Hexacosanoic acid | 24.78 | Mitochondrial dysfunction and Ca2+ deregulation | Hein et al. (2008) |
| 19. | Benzenepropanoic acid, | 27.99 | – | – |
| 20. | Ergosten-3β-ol | 28.10 | – | – |
| 21. | Butane, 2,3-bis(Trimethylsiloxy) | 30.25 | – | – |
| 22. | Undecenoic acid | 30.83 | – | – |
| 23. | 1-Monolinoleoylglycerol TMS ether | 32.25 | – | – |
| 24. | Spirostan-3-one (5α, 20β, 25R) | 33.61 | – | – |
| 25. | Cis-13-docosenoic acid | 33.84 | – | |
| 27. | Hexacosanoic acid | 34.10 | Mitochondrial dysfunction and Ca2+ deregulation | Hein et al. (2008) |
| 28. | Heptadecane, 2,6,10,15-tetramethyl | 34.89 | – | |
| 29. | Benzeneacetic acid, TMS ester | 35.45 | – | |
| 30. | Tetradecanoic acid, TMS ester | 36.06 | Skin and eyes | Burdock and Carabin (2007) |
| 31. | Tetradecanoic acid, ethyl ester | 36.45 | – | |
| 32. | Docosanoic acid, methyl ester | 37.44 | Mitochondrial dysfunction and Ca2+ deregulation | Hein et al. (2008) |
| 33. | Ethyl docosanoate | 38.10 | – | |
| 34. | Octadecanoic acid, 2,3-bis[(TMS)oxy]propyl ester | 38.12 | Acute lung injury | USEPA (2012) |
| 35. | Hexadecane | 39.17 | – | |
| 36. | Stigmasta-5,22-dien-3-ol(3β,22E) | 41.45 | EDC | USEPA (2012) |
| 37. | Stigmasterol | 42.19 | EDC | USEPA (2012) |
RT retention time (in min), EDC endocrine-disrupting chemical, TMS trimethylsilyl